Long-Term Assets: The sum of all assets classified as non-current.
Sagimet Biosciences Inc. (SGMT) had Long-Term Assets of $0.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-18.18M |
|
-- |
|
-- |
|
$19.86M |
|
$-19.86M |
|
$1.69M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-18.18M |
|
$-19.86M |
|
$-20.40M |
|
32.20M |
|
32.20M |
|
$-0.56 |
|
$-0.56 |
|
| Balance Sheet Financials | |
$146.07M |
|
-- |
|
|
Long-Term Assets |
$0.10M |
$146.17M |
|
$7.18M |
|
-- |
|
-- |
|
$7.18M |
|
$138.99M |
|
$138.99M |
|
$138.99M |
|
32.20M |
|
| Cash Flow Statement Financials | |
$-14.54M |
|
$3.41M |
|
-- |
|
$75.84M |
|
$64.72M |
|
$-11.12M |
|
$1.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.08% |
|
-13.08% |
|
-12.43% |
|
-13.08% |
|
$4.32 |
|
$-0.45 |
|
$-0.45 |
|